table of content
1 Study Coverage
1.1 In-Vitro Cancer Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2017-2022) & (US$ Million) Introduction
1.2 Global In-Vitro Cancer Diagnostics Outlook 2017 VS 2022 VS 2028
1.2.1 Global In-Vitro Cancer Diagnostics Market Size for the Year 2017-2028
1.2.2 Global In-Vitro Cancer Diagnostics Market Size for the Year 2017-2028
1.3 In-Vitro Cancer Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States In-Vitro Cancer Diagnostics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of In-Vitro Cancer Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 In-Vitro Cancer Diagnostics Market Dynamics
1.4.1 In-Vitro Cancer Diagnostics Industry Trends
1.4.2 In-Vitro Cancer Diagnostics Market Drivers
1.4.3 In-Vitro Cancer Diagnostics Market Challenges
1.4.4 In-Vitro Cancer Diagnostics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 In-Vitro Cancer Diagnostics by Type
2.1 In-Vitro Cancer Diagnostics Market Segment by Type
2.1.1 Instruments
2.1.2 Reagents and Kits
2.2 Global In-Vitro Cancer Diagnostics Market Size by Type (2017, 2022 & 2028)
2.3 Global In-Vitro Cancer Diagnostics Market Size by Type (2017-2028)
2.4 United States In-Vitro Cancer Diagnostics Market Size by Type (2017, 2022 & 2028)
2.5 United States In-Vitro Cancer Diagnostics Market Size by Type (2017-2028)
3 In-Vitro Cancer Diagnostics by Application
3.1 In-Vitro Cancer Diagnostics Market Segment by Application
3.1.1 Laboratories
3.1.2 Hospitals
3.1.3 Others
3.2 Global In-Vitro Cancer Diagnostics Market Size by Application (2017, 2022 & 2028)
3.3 Global In-Vitro Cancer Diagnostics Market Size by Application (2017-2028)
3.4 United States In-Vitro Cancer Diagnostics Market Size by Application (2017, 2022 & 2028)
3.5 United States In-Vitro Cancer Diagnostics Market Size by Application (2017-2028)
4 Global In-Vitro Cancer Diagnostics Competitor Landscape by Company
4.1 Global In-Vitro Cancer Diagnostics Market Size by Company
4.1.1 Top Global In-Vitro Cancer Diagnostics Companies Ranked by Revenue (2021)
4.1.2 Global In-Vitro Cancer Diagnostics Revenue by Player (2017-2022)
4.2 Global In-Vitro Cancer Diagnostics Concentration Ratio (CR)
4.2.1 In-Vitro Cancer Diagnostics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of In-Vitro Cancer Diagnostics in 2021
4.2.3 Global In-Vitro Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global In-Vitro Cancer Diagnostics Headquarters, Revenue in In-Vitro Cancer Diagnostics Business (2017-2022) & (US$ Million) Type
4.3.1 Global In-Vitro Cancer Diagnostics Headquarters and Area Served
4.3.2 Global In-Vitro Cancer Diagnostics Companies Revenue in In-Vitro Cancer Diagnostics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into In-Vitro Cancer Diagnostics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States In-Vitro Cancer Diagnostics Market Size by Company
4.5.1 Top In-Vitro Cancer Diagnostics Players in United States, Ranked by Revenue (2021)
4.5.2 United States In-Vitro Cancer Diagnostics Revenue by Players (2020, 2021 & 2022)
5 Global In-Vitro Cancer Diagnostics Market Size by Region
5.1 Global In-Vitro Cancer Diagnostics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global In-Vitro Cancer Diagnostics Market Size by Region (2017-2028)
5.2.1 Global In-Vitro Cancer Diagnostics Market Size by Region: 2017-2022
5.2.2 Global In-Vitro Cancer Diagnostics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America In-Vitro Cancer Diagnostics Market Size YoY Growth 2017-2028
6.1.2 North America In-Vitro Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific In-Vitro Cancer Diagnostics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific In-Vitro Cancer Diagnostics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe In-Vitro Cancer Diagnostics Market Size YoY Growth 2017-2028
6.3.2 Europe In-Vitro Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America In-Vitro Cancer Diagnostics Market Size YoY Growth 2017-2028
6.4.2 Latin America In-Vitro Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa In-Vitro Cancer Diagnostics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa In-Vitro Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 MDx Health Quest Diagnostics
7.1.1 MDx Health Quest Diagnostics Company Details
7.1.2 MDx Health Quest Diagnostics Business Overview
7.1.3 MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Introduction
7.1.4 MDx Health Quest Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2017-2022)
7.1.5 MDx Health Quest Diagnostics Recent Development
7.2 R-Biopharm AG
7.2.1 R-Biopharm AG Company Details
7.2.2 R-Biopharm AG Business Overview
7.2.3 R-Biopharm AG In-Vitro Cancer Diagnostics Introduction
7.2.4 R-Biopharm AG Revenue in In-Vitro Cancer Diagnostics Business (2017-2022)
7.2.5 R-Biopharm AG Recent Development
7.3 Signature Diagnostics
7.3.1 Signature Diagnostics Company Details
7.3.2 Signature Diagnostics Business Overview
7.3.3 Signature Diagnostics In-Vitro Cancer Diagnostics Introduction
7.3.4 Signature Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2017-2022)
7.3.5 Signature Diagnostics Recent Development
7.4 Siemens Healthcare
7.4.1 Siemens Healthcare Company Details
7.4.2 Siemens Healthcare Business Overview
7.4.3 Siemens Healthcare In-Vitro Cancer Diagnostics Introduction
7.4.4 Siemens Healthcare Revenue in In-Vitro Cancer Diagnostics Business (2017-2022)
7.4.5 Siemens Healthcare Recent Development
7.5 Randox Laboratories
7.5.1 Randox Laboratories Company Details
7.5.2 Randox Laboratories Business Overview
7.5.3 Randox Laboratories In-Vitro Cancer Diagnostics Introduction
7.5.4 Randox Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2017-2022)
7.5.5 Randox Laboratories Recent Development
7.6 Epigenomics AG
7.6.1 Epigenomics AG Company Details
7.6.2 Epigenomics AG Business Overview
7.6.3 Epigenomics AG In-Vitro Cancer Diagnostics Introduction
7.6.4 Epigenomics AG Revenue in In-Vitro Cancer Diagnostics Business (2017-2022)
7.6.5 Epigenomics AG Recent Development
7.7 Beckman Coulter
7.7.1 Beckman Coulter Company Details
7.7.2 Beckman Coulter Business Overview
7.7.3 Beckman Coulter In-Vitro Cancer Diagnostics Introduction
7.7.4 Beckman Coulter Revenue in In-Vitro Cancer Diagnostics Business (2017-2022)
7.7.5 Beckman Coulter Recent Development
7.8 Abbott Laboratories
7.8.1 Abbott Laboratories Company Details
7.8.2 Abbott Laboratories Business Overview
7.8.3 Abbott Laboratories In-Vitro Cancer Diagnostics Introduction
7.8.4 Abbott Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2017-2022)
7.8.5 Abbott Laboratories Recent Development
7.9 Burning Rock
7.9.1 Burning Rock Company Details
7.9.2 Burning Rock Business Overview
7.9.3 Burning Rock In-Vitro Cancer Diagnostics Introduction
7.9.4 Burning Rock Revenue in In-Vitro Cancer Diagnostics Business (2017-2022)
7.9.5 Burning Rock Recent Development
7.10 Novogene
7.10.1 Novogene Company Details
7.10.2 Novogene Business Overview
7.10.3 Novogene In-Vitro Cancer Diagnostics Introduction
7.10.4 Novogene Revenue in In-Vitro Cancer Diagnostics Business (2017-2022)
7.10.5 Novogene Recent Development
7.11 Geneseeq
7.11.1 Geneseeq Company Details
7.11.2 Geneseeq Business Overview
7.11.3 Geneseeq In-Vitro Cancer Diagnostics Introduction
7.11.4 Geneseeq Revenue in In-Vitro Cancer Diagnostics Business (2017-2022)
7.11.5 Geneseeq Recent Development
7.12 Amoy Diagnostics Co.,Ltd.
7.12.1 Amoy Diagnostics Co.,Ltd. Company Details
7.12.2 Amoy Diagnostics Co.,Ltd. Business Overview
7.12.3 Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Introduction
7.12.4 Amoy Diagnostics Co.,Ltd. Revenue in In-Vitro Cancer Diagnostics Business (2017-2022)
7.12.5 Amoy Diagnostics Co.,Ltd. Recent Development
7.13 Daan Gene
7.13.1 Daan Gene Company Details
7.13.2 Daan Gene Business Overview
7.13.3 Daan Gene In-Vitro Cancer Diagnostics Introduction
7.13.4 Daan Gene Revenue in In-Vitro Cancer Diagnostics Business (2017-2022)
7.13.5 Daan Gene Recent Development
7.14 Fosun Pharma
7.14.1 Fosun Pharma Company Details
7.14.2 Fosun Pharma Business Overview
7.14.3 Fosun Pharma In-Vitro Cancer Diagnostics Introduction
7.14.4 Fosun Pharma Revenue in In-Vitro Cancer Diagnostics Business (2017-2022)
7.14.5 Fosun Pharma Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
